Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 804 results for "eisai"

Asian Stocks Are Little Changed After Five-Day Gain; Eisai Jumps

(Bloomberg) -- Asian stocks were little changed, after the regional benchmark posted five days of gains. China's Shanghai Composite Index capped its longest winning streak since 1992. Eisai jumped 9.4 percent to extend a record high in Tokyo after ... La Repubblica, 4 days ago

45 images for eisai

American Banking News, 5 days ago
Livemint.com, 5 days ago
Pharma Letter, 1 week ago
Asian Scientist, 2 weeks ago
Yahoo! Finance, 3 weeks ago
Pharmaceutical Technology, 2 weeks ago
Pharmafocus, 3 weeks ago
Xconomy, 2 weeks ago
Seeking Alpha, 2 weeks ago
BioSpace, 4 weeks ago

Japan Stocks Swing as Textile Makers Gain, Energy Explorers Drop

(Bloomberg) -- Japanese stocks swung between gains and losses as textile makers rose and energy explorers fell. Eisai Co. fell 5 percent as investors took profits after the drugmaker jumped 30 percent over the past two trading sessions. Toyo ...
 La Repubblica3 days ago Japan Stocks Climb Second Day This Week on Utilities  La Repubblica3 days ago Japanese Stocks Fall for Second Day as Drugmakers Lead Declines  Bloomberg3 days ago Topix Swings as Drugmakers Fall and Electricity Generators Gain  La Repubblica3 days ago
Business Recorder

Nikkei edges down after US shares fall; cum-dividend buying limits losses

* Eisai drops on after soaring 32 pct over the last 2 days * Positive themes about Japan market may continue - analyst By Ayai Tomisawa TOKYO, March 25 (Reuters) - Japan's Nikkei share average edged down on Wednesday morning in choppy trade as U.S. shares ...
 Sify3 days ago Nikkei falls on soft PMI, weak U.S. shares trigger profit-taking  CNBC4 days ago Nikkei falls on soft PMI, weak US shares trigger profit-taking  Business Recorder4 days ago Nikkei falls 0.3% on soft PMI, weak US shares trigger profit-taking  Economic Times4 days ago
[x]  

Eisai Bags CII's EHS Excellence Award

VISAKHAPATNAM:The Confederation of Indian Industry (CII), Southern Region, has conferred its prestigious Environment, Health, and Safety (EHS) Excellence 2014 award on Eisai Pharmatechnology and Manufacturing Private Limited, Visakhapatnam. The ...
 New Indian Express1 week ago Eisai bags CII excellence award  The Hindu1 week ago
Livemint.com

Nikkei rises to fresh 15-year high; drugmaker Eisai soars after upgrade

* Eisai jumps 20 pct on Barclays' rating hike citing Alzheimer's drug hope * Sharp soars after Hon Hai says it is considering rescuing * Nikkei's 20,000 in sight near term - analysts TOKYO, March 23 (Reuters) - ...
 CNBC5 days ago REUTERS - Nikkei rises to fresh 15-year high; Eisai soars on hopes for Alzheimer's drug  Namibia Press Agency5 days ago Nikkei at New 15-Year High, Eisai Soars 20%  123Jump5 days ago Nikkei hits another 15-year high on climb in overseas markets  Japan Times5 days ago
[x]  

Eisai and Epizyme to change scope of collaboration

Eisai Co., Ltd. and Epizyme, Inc. have agreed to change the scope of collaboration for their partnership initiated in March 2011 to discover, develop and commercialize cancer therapeutics targeting EZH2, an epigenetic enzyme. In March 2011, Eisai ...
 Individual.com5 days ago

Japanese Shares Head for Seven-Year High as Eisai Leads Advance

(Bloomberg) -- Japan's Topix index headed for a seven-year high as expectations the Federal Reserve will be slower to raise interest rates boosted global equities. Eisai Co. soared 21 percent to its daily limit after the results of a study on a ...
 La Repubblica5 days ago Japanese Shares Close at Seven-Year High as Eisai Leads Advance  La Repubblica5 days ago

Eisai Shares Jump Most on Record on Alzheimer's Drug Data

(Adds Eisai's business strategy seventh paragraph.) The Japanese drugmaker's shares climbed as much as 21 percent to 8,748 yen in Tokyo trading today, headed for the largest gain since Bloomberg started tracking the data in 1974. The benchmark ...
 La Repubblica5 days ago

Eisai Jumps Most on Record on Successful Alzheimer's Drug Data

(Bloomberg) -- Eisai Co.'s shares had the biggest gain on record after partner Biogen Idec Inc.'s experimental drug for Alzheimer's slowed progression of the disease in an early-stage study. The Japanese drugmaker's shares climbed as much as 21 ...
 Bloomberg5 days ago
Reuters

EISAI RECEIVES APPROVAL IN JAPAN FOR ANTICANCER AGENT LENVIMA® (LENVATINIB MESYLATE) AS TREATMENT FOR UNRESECTABLE THYROID CANCER

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, Eisai) announced today that it has received manufacturing and marketing authorization in Japan for its in-house developed novel anticancer agent Lenvima® (lenvatinib mesylate) indicated for ...
 PharmiWeb2 days ago FDA approves Eisai's thyroid cancer drug  Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less